Product Information

HYDROMORPHONE 8 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.5683 per EA under NDC 42858030301. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 7, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROMORPHONE 8 MG TABLET

Hydromorphone Hydrochloride
$0.5683per EA
DEA Schedule CII

Strength

8 mg/1

NDC

42858030301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019892

FDA Approved

12/7/1992

TE Code

AB

On Market Since

11/23/2009

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for HYDROMORPHONE 8 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 28.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5683 per EA
All-time high$0.5683 (Aug 19, 2026)
All-time low$0.2311 (Nov 20, 2019)
52-week high$0.5683
52-week low$0.5470
Median price$0.3138
Average price$0.3555
Largest weekly change+25.0% (Aug 23, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.1%

1M

+0.1%

3M

+1.2%

6M

+0.0%

1Y

+2.8%

3Y

+99.7%

5Y

+91.7%

All

+28.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROMORPHONE 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 8 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.5683 per EA (NDC 42858030301), effective Aug 19, 2026.

How has the price of HYDROMORPHONE 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROMORPHONE 8 MG TABLET has risen 28.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 8 MG TABLET?

Since Nov 28, 2013, the NADAC for HYDROMORPHONE 8 MG TABLET has ranged from a low of $0.2311 (Nov 20, 2019) to a high of $0.5683 (Aug 19, 2026), with a median of $0.3138 per EA.

Are there cheaper alternatives to HYDROMORPHONE 8 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROMORPHONE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROMORPHONE 8 MG TABLET?

HYDROMORPHONE 8 MG TABLET (NDC 42858030301) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.